Search filters

List of works by Vibeke Kruse

A phase II trial of stereotactic body radiotherapy with concurrent anti-PD1 treatment in metastatic melanoma: evaluation of clinical and immunologic response

scientific article published on 31 January 2017

Burden of skin cancer in Belgium and cost-effectiveness of primary prevention by reducing ultraviolet exposure

scientific article published on 3 October 2016

CA 15.3 measurements for separating FDG PET/CT positive from negative findings in breast carcinoma recurrence. Factors influencing the area under the ROC curve

scientific article published in August 2014

Challenging PD-L1 expressing cytotoxic T cells as a predictor for response to immunotherapy in melanoma

scientific article published in Nature Communications

Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial.

scientific article published on 3 March 2017

Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis.

scientific article published on 11 December 2016

Cost-effectiveness and Budget Effect Analysis of a Population-Based Skin Cancer Screening

scientific article published on 14 December 2016

High dose chemotherapy and stem cell rescue for metastatic germ cell tumours: long-term results from a single institution.

scientific article published in July 2011

Imaging requirements for personalized medicine: the oncologists point of view.

scientific article published on January 2014

Immune checkpoint blockade for organ transplant patients with advanced cancer: how far can we go?

scientific article published on 01 March 2019

Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports.

scientific article

NS-417, a novel compound with neurotrophic-like effects.

scientific article

Nephrotoxicity of anticancer drugs--an underestimated problem?

scientific article published on September 2011

Peritumoral endothelial indoleamine 2, 3-dioxygenase expression is an early independent marker of disease relapse in colorectal cancer and is influenced by DNA mismatch repair profile.

scientific article published on 18 May 2018

Peritumoral indoleamine 2,3-dioxygenase expression in melanoma: an early marker of resistance to immune control?

scientific article published on 6 October 2014

Phase 1 Dose Escalation Trial of Ipilimumab and Stereotactic Body Radiation Therapy in Metastatic Melanoma

scientific article published on 24 November 2017

Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma

scientific article published on 03 April 2019

Psoriasis Vulgaris Exacerbation during Treatment with a PD-1 Checkpoint Inhibitor: Case Report and Literature Review

article

Reproducibility of FDG PET based metabolic tumor volume measurements and of their FDG distribution within

scientific article published on 3 April 2014

Serum tumor markers and PET/CT imaging for tumor recurrence detection.

scientific article published on 04 December 2012

Stable metabolic disease on FDG-PET provides information on response to endocrine therapy for breast cancer

scientific article published on 7 October 2014

Successful strategy to treat a solitary cystic melanoma brain metastasis

scientific article published on 29 September 2016

Sunitinib for metastatic renal cell cancer patients: observational study highlighting the risk of important drug-drug interactions.

scientific article

Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?

scientific article published on August 2015

The addition of bevacizumab to standard chemotherapy in breast cancer: which patient benefits the most?

scientific article published on May 2013

The impact of logarithmic dose banding of anticancer drugs on pharmacy compounding efficiency at Ghent University Hospital

scientific article published on 04 March 2017

The rationale of indoleamine 2,3-dioxygenase inhibition for cancer therapy.

scientific article

Throughput efficiency and service quality after process redesign at a cancer day care unit: Two sides of the coin?

article

Paulina is supported by:

About Paulina

Help